A single-shot coronavirus vaccine from Johnson & Johnson will be tested in 60,000 people
Three other candidates have a head start, but J&J’s vaccine could be easier to administer and distribute if it is proved safe and effective. Read Article
As Fall Arrives and Pressures Mount, Harvard Medical Researchers Press Forward on Two COVID Vaccine Trials
Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, Dan H. Barouch is heading a COVID-19 vaccine effort in a partnership with pharmaceutical company Johnson & Johnson. Read Article
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down? Read Article
The big question over a Covid vaccine: Is it coming too fast to be trusted?
Dr Kathryn Stephenson, director of the Clinical Trials Unit for the Centre for Virology and Vaccine Research at Harvard University’s Beth Israel Deaconess Medical Centre, told The Independent that the vaccine clinical trials she’s seen are all being conducted with the same safety measures as past trials. Read Article
HMSRobust protection
COVID-19 vaccine candidate at Beth Israel prevents severe clinical disease in animals. Read Article
The Importance of Diversifying Covid Clinical Trials
In this edition of “Bloomberg Equality,” Dr. Kathryn Stephenson of Harvard Medical School talks with Bloomberg’s Scarlet Fu about the history of Black and Latino communities feeling left out of the American health care system and the importance of diversifying coronavirus vaccine clinical trials. Watch Article
NYTScientists See Downsides to Top COVID-19 Vaccines From Russia, China
“Demonstrating safety and efficacy of a vaccine is very important,” said Dr. Dan Barouch, a Harvard vaccine researcher who helped design J&J’s COVID-19 vaccine. Read Article
Scientists see downsides to top COVID-19 vaccines from Russia, China
Many experts expressed skepticism about the Russian vaccine after the government declared its intention to give it to high-risk groups in October without data from large pivotal trials. Read Article
Four scenarios on how we might develop immunity to Covid-19
As the world wearies of trying to suppress the SARS-CoV-2 virus, many of us are wondering what the future will look like as we try to learn to live with it. Read Article
ABCNEWS1st documented COVID-19 reinfection isn’t surprising, but may offer important clues about virus, experts say
“It’s an interesting and important case report. It answers the question [of] whether it’s possible to get re-infected: The answer is yes.” – Dan Barouch Read Article
